TheEdgeResearch
Home / Stocks / EW

Edwards Lifesciences Corporation (EW)

NYSE Healthcare Medical - Devices
$85.98 ▲ +0.26%
Market Cap
$49.51B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.85
52-Wk Range
72.3-96.29
CEO
Bernard J. Zovighian
Country
US
Currency
USD

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and…

Open full interactive analysis & DCF →